安杰思: 安杰思2024年年度股东大会决议公告

Core Viewpoint - The shareholders' meeting of Hangzhou Anjisi Medical Technology Co., Ltd. was held on May 16, 2025, with all proposed resolutions approved by the shareholders [1][6]. Meeting Details - The meeting took place at Room 302, 3rd Floor, No. 389 Xingzhong Road, Linping District, Hangzhou [1]. - A total of 48 ordinary shareholders attended the meeting, holding 57,830,094 voting rights, which accounted for 71.77% of the company's total voting rights [1]. Voting Results - All non-cumulative voting proposals were approved, with the following voting results: - Proposal 1: 57,694,589 votes in favor (99.77%), 121,105 votes against (0.21%), and 14,400 abstentions (0.03%) [2]. - Proposal 2: 57,691,389 votes in favor (99.76%), 124,305 votes against (0.21%), and 14,400 abstentions (0.03%) [2]. - Proposal 3: 57,692,589 votes in favor (99.76%), 137,505 votes against (0.24%), and no abstentions [3]. Election of Directors - The election of directors was conducted with the following results: - Zhang Cheng was elected with 55,363,070 votes (95.73%) [3]. - Zhang Qianyi was elected with 55,363,071 votes (95.73%) [3]. - Shen Menghui was elected with 55,392,711 votes (95.79%) [4]. - Feng Yang was elected with 55,392,710 votes (95.79%) [4]. Legal Compliance - The meeting and voting procedures complied with the Company Law and the company's articles of association, ensuring the legality and validity of the resolutions passed [6].